Condiciones de salud que jiaogulan puede ayudar a apoyar.
Jiaogulan gypenosides are documented antioxidants that activate Nrf2/ARE signaling, increase superoxide dismutase (SOD) and glutathione peroxidase activity, scavenge reactive oxygen species, and protect cells from oxidative damage in multiple in vitro and animal studies, including human cell line work.
A 2019 clinical study found that jiaogulan supplementation reduced anxiety proneness in subjects under chronic psychological stress, as measured by a decrease in State-Trait Anxiety Inventory (T-STAI) scores. Animal models corroborate anxiolytic effects of gypenosides. Traditional use as an adaptogen in southern China also emphasized its role in stress resilience.
Jiaogulan protects arterial walls by lowering LDL cholesterol and triglycerides, raising HDL, and stimulating nitric oxide production to support healthy vasodilation. A 1999 in vitro study confirmed direct nitric oxide release by gypenosides. Multiple Chinese RCTs reported in a 2022 systematic review document lipid-lowering effects in dyslipidemic populations.
A randomized, double-blind, placebo-controlled crossover trial found that jiaogulan supplementation enhanced 20 km time-trial cycling performance in healthy males, associated with improved mitochondrial oxidative capacity and increased AMPK phosphorylation during exercise. Animal studies also show anti-fatigue effects via increased muscle and liver glycogen.
A double-blind clinical trial showed jiaogulan achieved an 82% success rate in reducing high blood pressure, nearly matching indapamide (93%) and substantially outperforming Panax ginseng (46%). The mechanism involves stimulation of endothelial nitric oxide production leading to vasodilation.
Multiple human clinical trials demonstrate that jiaogulan tea significantly lowers fasting blood glucose and HbA1c in type 2 diabetic patients, primarily by improving insulin sensitivity. A 12-week RCT (n=24) found a ~3.0 mmol/L reduction in fasting glucose and ~2% decrease in HbA1c vs. controls.
A 2022 systematic review of 22 RCTs (2,407 participants) found G. pentaphyllum effective for normalizing serum cholesterol in dyslipidemia, lowering LDL and total cholesterol while raising HDL. The RxList monograph also notes evidence for decreased total cholesterol and improved HDL/total ratio.
Jiaogulan (Gynostemma pentaphyllum) is used in Chinese traditional medicine as an adaptogen for fatigue, stamina, and longevity. Its gypenosides activate AMPK, supporting mitochondrial energy metabolism. Clinical studies show improved exercise performance and reduced fatigue, and it is called the 'herb of immortality' in southern Chinese folk medicine.
Jiaogulan gypenosides suppress pro-inflammatory signaling via inhibition of NF-κB and MAPK pathways, reducing TNF-α, IL-1β, and IL-6. A small human study (n=24) found decreased C-reactive protein in subjects with mild hypertension after jiaogulan tea.
Jiaogulan promotes circulation via endothelial nitric oxide production, which dilates blood vessels, and by inhibiting platelet aggregation, reducing the risk of abnormal clot formation. These effects are supported by in vitro studies on gypenosides and multiple cardiovascular clinical studies.
A 2026 peer-reviewed ScienceDirect review identified jiaogulan as a neuroprotective agent targeting Alzheimer's disease, Parkinson's disease, and age-related cognitive decline via antioxidant, anti-inflammatory, neurogenic, and cholinesterase-inhibiting mechanisms. Preclinical models demonstrate protection of hippocampal and cortical neurons.
Preclinical evidence shows antidepressant-like effects of standardized gypenosides through inhibition of neuroinflammation and modulation of brain-derived neurotrophic factor (BDNF) signaling in the hippocampus. These findings come from animal models; no dedicated human RCT for depression has been published.
A 2022 peer-reviewed review in Food Science & Nutrition (PubMed-indexed) documented jiaogulan's prebiotic potential, showing that its saponins and polysaccharides modulate gut microbiota composition. Animal studies show it increases beneficial bacteria (Akkermansia, Lactococcus) and reduces harmful strains in NAFLD and NASH models.
Jiaogulan (Gynostemma pentaphyllum) is a Chinese herb nicknamed the 'herb of immortality' with gypenosides that activate AMPK — the same cellular energy sensor targeted by longevity drugs. Clinical trials show jiaogulan extract improves insulin sensitivity, reduces lipid levels, and exhibits anti-inflammatory effects relevant to metabolic aging.
A 12-week randomized, double-blind, placebo-controlled trial (n=80) of actiponin—a heat-processed G. pentaphyllum extract—found significant reductions in total abdominal fat area, body weight, body fat mass, percent body fat, and BMI vs. placebo in obese Korean adults.
Jiaogulan supports heart health through multiple mechanisms: lowering blood pressure and LDL/triglycerides, raising HDL, stimulating nitric oxide production, and protecting cardiac muscle cells from ischemia-reperfusion injury. Clinical and in vitro studies support these cardiovascular benefits.
Jiaogulan (Gynostemma pentaphyllum) is the same plant known by its Chinese name, used in traditional medicine as an adaptogen and metabolic herb. Its gypenosides activate AMPK, and clinical trials have shown significant reductions in insulin resistance (HOMA-IR) in NAFLD patients and improvements in blood glucose in T2DM/prediabetic populations.
Jiaogulan gypenosides protect liver cells from oxidative stress, lipid accumulation, and inflammatory injury. Animal studies and in vitro work document hepatoprotective mechanisms; a 6-month human clinical study reported positive results as an add-on treatment for non-alcoholic fatty liver disease (NAFLD).
Gypenosides improved spatial learning and memory in a rat model of chronic cerebral hypoperfusion by suppressing oxidative stress and astrocytic activation in the cortex and hippocampus. Additional rodent studies show protection of hippocampal cells from hypoxia/hypoglycemia injury.
A registered clinical trial (NCT05118698, First Affiliated Hospital Xi'an Jiaotong University) is investigating jiaogulan specifically in metabolic syndrome patients. Jiaogulan's effects on blood sugar, triglycerides, blood pressure, and abdominal obesity—the core components of metabolic syndrome—are individually supported by clinical evidence.
Jiaogulan activates AMPK—the master metabolic regulator—promoting fat oxidation, improving insulin sensitivity, reducing hepatic lipogenesis, and enhancing mitochondrial biogenesis. These metabolic effects are supported by both in vitro, animal, and human clinical data.
A 1999 peer-reviewed study (Tanner et al., Nitric Oxide journal) confirmed that gypenosides directly release nitric oxide in vitro. Multiple subsequent studies have linked jiaogulan's blood pressure and arterial effects to endothelial NO stimulation.
Multiple preclinical studies demonstrate that gypenosides protect dopaminergic neurons in rodent models of Parkinson's disease (6-OHDA and MPTP models). Additionally, gypenosides attenuate L-DOPA-induced dyskinesia in animal models. No human clinical trial has been conducted.
Jiaogulan has been shown to lower serum triglycerides in multiple studies, achieving this by improving hepatic fat metabolism and redirecting carbohydrates toward muscle energy rather than triglyceride synthesis. A 2022 systematic review of 22 RCTs in 2,407 dyslipidemia patients supports its lipid-lowering efficacy.
Jiaogulan is listed as a traditional treatment for chronic bronchitis in both the RxList and Drugs.com medical monographs, reflecting documented historical use in Chinese folk medicine for respiratory conditions including cough and chronic bronchitis.
Jiaogulan has been consumed for centuries in southern China as an evening tea specifically to relieve fatigue and promote relaxation. Its adaptogenic properties are described as biphasic—energizing when needed and calming when the body is stressed—consistent with HPA axis modulation.
Jiaogulan has been used for centuries in southern China as a morning energy tonic, consumed as a tea to increase strength and endurance throughout the day. Its adaptogenic, AMPK-activating, and anti-fatigue properties provide a plausible pharmacological basis for this traditional use.
Jiaogulan (Gynostemma pentaphyllum), known as 'southern ginseng,' contains gypenosides related to ginsenosides and has adaptogenic properties documented in animal studies, including HPA axis cortisol normalization under chronic stress. Listed in HPA axis support databases and integrative protocols as an adaptogen adjunct. Robust human RCTs measuring cortisol are lacking.
Jiaogulan has traditionally been used in southern China for sleep difficulties and is listed in the RxList monograph as a traditional use for insomnia. No dedicated human RCT has been conducted for insomnia as a primary endpoint; the effect is attributed to its adaptogenic, HPA-modulating properties.
Jiaogulan (Gynostemma pentaphyllum) is a Chinese adaptogenic herb used for centuries to combat fatigue and improve mental vitality. Its gypenosides are structurally similar to Panax ginseng ginsenosides, and limited clinical evidence supports adaptogenic mental energy effects.
Jiaogulan (Gynostemma pentaphyllum) is a traditional Chinese herbal tonic used for centuries in southern China for longevity, endurance, and anti-fatigue. Its gypenosides activate AMPK pathways, supporting mitochondrial biogenesis and energy metabolism. Animal studies confirm anti-fatigue effects; limited human data support its adaptogenic and stamina-enhancing properties.
Jiaogulan (Gynostemma pentaphyllum) is a traditional Chinese medicinal herb used for recovery from illness and fatigue, with adaptogenic properties similar to ginseng. It contains gypenosides structurally similar to ginsenosides and has documented immunomodulatory and antioxidant properties. Traditional use for post-illness weakness and immune support in Guizhou Province (China) is well-documented.
Gynostemma pentaphyllum, a TCM adaptogen ('southern ginseng') with documented anxiolytic and adaptogenic properties. Preclinical models confirm anxiety reduction, and it was included in a 2023 systematic review of adaptogenic plants with clinical RCT evidence for stress. Used in traditional Asian medicine for stress, fatigue, and longevity.
Volver